Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) regularly issues news and updates as a producer and marketer of plant-based and innovative wellness products. With its roots in agricultural innovation and a current focus on Zola coconut water and related wellness offerings, the company’s announcements provide insight into its operating performance, strategic direction, and capital markets activity.
News items for RKDA often include quarterly and annual financial results, where Arcadia reports revenue trends, gross margin performance, and changes in operating expenses. These releases detail how Zola coconut water revenues and distribution have evolved over time, and how asset sales, credit losses, and fair value changes in financial instruments have affected net income or loss attributable to common stockholders.
Arcadia’s news flow also covers strategic transactions and corporate actions. Examples include the sale of its GoodWheat brand and wheat-related intellectual property, agreements to transfer or terminate certain patent rights, and the previously announced but later terminated proposed business combination with Roosevelt Resources, LP. Press releases describe the rationale for these actions and their role in streamlining operations and evaluating strategic alternatives.
Investors following RKDA news will also see capital-raising and securities-related announcements, such as inducement transactions involving preferred investment options and the issuance of new options and placement agent options, as disclosed in company filings and related press releases. In addition, Arcadia publishes notices about upcoming earnings releases, conference calls, and virtual stockholder meetings, along with proxy and governance information.
This news page aggregates these disclosures so readers can review Arcadia’s earnings reports, transaction updates, financing developments, and governance communications in one place. For those tracking RKDA, the feed offers a structured view of how the company describes its business focus, financial condition, and strategic plans over time.
Arcadia Biosciences (Nasdaq: RKDA) announced its participation in the H.C. Wainwright Global Life Sciences Conference scheduled for March 9-10, 2021. The company aims to showcase its innovative approaches to enhancing crop quality and nutritional value through scientific methods. President and CEO Matt Plavan will provide an overview of the business and engage in one-on-one meetings with investors. The presentation will be available on-demand starting March 9 at 7:00 AM (EST) and will include a replay accessible via the company’s website.
Arcadia Biosciences (Nasdaq: RKDA) announced the appointment of Debbie Carosella to its board of directors. Carosella, former CEO of Madhava Natural Sweeteners, brings extensive experience in the food industry, having held leadership roles at Dean Foods and ConAgra Foods. Her expertise in consumer marketing and brand development is expected to enhance Arcadia's commercial strategy for its health-focused products, GoodWheat™ and GoodHemp™. CEO Kevin Comcowich expressed confidence in her ability to drive innovation and growth for the company's product lines.
Arcadia Biosciences (Nasdaq: RKDA) announced that its GoodHemp™ seed varieties – Rogue, Umpqua, Santiam, and Potomac – have achieved certification from the Association of Official Seed Certifying Agencies (AOSCA). This certification ensures quality assurance and varietal purity, crucial for growers in the hemp industry. AOSCA-certified seeds are eligible for certified hemp seed production, meeting stringent U.S. Seed Act standards. The varieties are designed to enhance yield and are available for planting in states like Florida, boosting the company's position in the hemp market.
On January 25, 2021, Arcadia Biosciences (Nasdaq: RKDA) announced a private placement, raising approximately $25.1 million by selling 7,876,784 shares at $3.1925 per share. The company will also issue warrants for up to 3,938,392 shares at an exercise price of $3.13. The funds will be allocated towards general corporate purposes, including the expansion of the GoodWheat™ brand and e-commerce initiatives. The offering is expected to close on or about January 27, 2021.
Arcadia Biosciences (Nasdaq: RKDA) has successfully closed a registered direct offering of 2,618,658 shares, priced at $2.93 per share, yielding approximately $7.7 million in gross proceeds. In a concurrent private placement, the company issued warrants for an additional 2,618,658 shares at $0.125 each, generating about $327,000. The net proceeds, estimated at $7.3 million, will primarily fund customer acquisition for GoodWheat and related marketing initiatives, supporting revenue growth strategies into 2021 amid potential economic volatility.
Arcadia Biosciences (Nasdaq: RKDA) announced a registered direct offering of 2,618,658 shares at a price of $3.055 per share, aiming to raise approximately $8 million in gross proceeds. The offering includes warrants to purchase an equal number of shares at an exercise price of $3.00, exercisable immediately and expiring in five and a half years. The funds will support customer acquisition for GoodWheat, digital marketing, and corporate costs. The closing is expected around December 22, 2020.
Arcadia Biosciences (Nasdaq: RKDA) announced a distribution agreement with Tritium 3H, Inc. for its GoodHemp seed varieties in Canada. The agreement follows extensive field tests and will see the initial distribution of three CBD dominant varieties: Umpqua, Rogue, and Santiam. AOSCA certification is expected in mid-December, with Health Canada certification anticipated in February. CEO Matt Plavan emphasized the commercialization acceleration of Arcadia's hemp genetics, while Tritium CEO Jayme Hunter praised the performance of the seeds in Canadian trials.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced third-quarter 2020 results, reporting revenues of $314,000, down 20% from $392,000 in Q3 2019. Operating expenses increased to $7.9 million, while the net loss attributable to common shareholders decreased to $6.4 million, or ($0.60) per share, reflecting a $7.8 million drop compared to the previous year. Key strategic transactions with Bioceres Crop Solutions will enhance commercialization efforts of HB4 soybeans and GoodWheat products. The company received $6 million in cash and equity from these deals.
Arcadia Biosciences (Nasdaq: RKDA) and Three Farm Daughters have launched new food products using Arcadia's non-GMO GoodWheat™ ingredients. The initial offerings include Artisan Linguine, Fusilli, Fettuccine Pasta, and 100% Wheat Flour, available online from November 12 and in select North Dakota and Minnesota stores. GoodWheat™ boasts up to nine times the fiber of traditional wheat and lower gluten and calorie content. This partnership addresses a fiber deficiency in American diets, aiming to provide consumers with healthier family food staples.
Arcadia Biosciences, Inc. (Nasdaq: RKDA) will release its third-quarter financial and business results after the market closes on November 12, 2020. A conference call is scheduled for 4:30 p.m. Eastern time to discuss the results and strategic achievements. Participants can join via U.S. toll-free at +1-844-243-4690 or internationally at +1-225-283-0138, using passcode 1303009. A live webcast will also be available on the company's website.